# Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer

> **NCT03026452** · PHASE1,PHASE2 · UNKNOWN · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 400 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **PROCEDURE:** US-guided RFA

## Key facts

- **NCT ID:** NCT03026452
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2018-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03026452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03026452, "Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03026452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*